
Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2024-2030
Description
Clinical Trial Imaging Market by Product & Service (Services, Software), Modality (Computed Tomography, Echocardiography, Magnetic Resonance Imaging), Therapeutic area, End-User - Global Forecast 2024-2030
The Clinical Trial Imaging Market size was estimated at USD 1.10 billion in 2023 and expected to reach USD 1.18 billion in 2024, at a CAGR 7.13% to reach USD 1.79 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Clinical Trial Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Clinical Trial Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Clinical Trial Imaging Market, highlighting leading vendors and their innovative profiles. These include Anagram 4 Clinical Trials, Biospective Inc., BioTelemetry by Koninklijke Philips N.V., Boston Imaging Core Lab LLC, Calyx Group, Cardiovascular Imaging Technologies LLC, Clario, Dassault Systèmes, Icon PLC, Imaging Endpoints LI, LLC, Ixico PLC, Medical Metrics Inc. by Catalent, Inc., Micron Inc., ProScan Imaging LLC, and Resonance Health Ltd..
Market Segmentation & Coverage
This research report categorizes the Clinical Trial Imaging Market to forecast the revenues and analyze trends in each of the following sub-markets:
Product & Service
Services
Operational Imaging Services
Read Analysis Services
System & Technical Support Services
Trial Design & Consulting Services
Software
Modality
Computed Tomography
Echocardiography
Magnetic Resonance Imaging
Positron Emission Tomography
Ultrasound
X-Ray
Therapeutic area
CVS
Endocrinology
Immunological Disorder
Infectious Diseases
Neurology
Oncology
End-User
Academic & Government Research Institutes
Biotechnology Companies
Contract Research Organizations
Medical Device Manufacturer
Pharmaceutical Companies
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Clinical Trial Imaging Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Clinical Trial Imaging Market?
3. What are the technology trends and regulatory frameworks in the Clinical Trial Imaging Market?
4. What is the market share of the leading vendors in the Clinical Trial Imaging Market?
5. Which modes and strategic moves are suitable for entering the Clinical Trial Imaging Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
187 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Clinical Trial Imaging Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Significant investments made in drug development programs
- 5.1.1.2. Significant reduction in the drug development and approval timelines
- 5.1.1.3. A non-invasive method of study and usability when a biopsy is not possible
- 5.1.2. Restraints
- 5.1.2.1. Data security and privacy issues and possibility of misusing the images obtained for studies
- 5.1.3. Opportunities
- 5.1.3.1. Development of cloud-based platform simplifying the process of image sharing
- 5.1.3.2. Integration of artificial intelligence (AI) to minimize errors and maximize efficiency
- 5.1.4. Challenges
- 5.1.4.1. High cost associated with the imaging techniques and potential exposure to prohibitive radiation
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Clinical Trial Imaging Market, by Product & Service
- 6.1. Introduction
- 6.2. Services
- 6.3.1. Operational Imaging Services
- 6.3.2. Read Analysis Services
- 6.3.3. System & Technical Support Services
- 6.3.4. Trial Design & Consulting Services
- 6.3. Software
- 7. Clinical Trial Imaging Market, by Modality
- 7.1. Introduction
- 7.2. Computed Tomography
- 7.3. Echocardiography
- 7.4. Magnetic Resonance Imaging
- 7.5. Positron Emission Tomography
- 7.6. Ultrasound
- 7.7. X-Ray
- 8. Clinical Trial Imaging Market, by Therapeutic area
- 8.1. Introduction
- 8.2. CVS
- 8.3. Endocrinology
- 8.4. Immunological Disorder
- 8.5. Infectious Diseases
- 8.6. Neurology
- 8.7. Oncology
- 9. Clinical Trial Imaging Market, by End-User
- 9.1. Introduction
- 9.2. Academic & Government Research Institutes
- 9.3. Biotechnology Companies
- 9.4. Contract Research Organizations
- 9.5. Medical Device Manufacturer
- 9.6. Pharmaceutical Companies
- 10. Americas Clinical Trial Imaging Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Clinical Trial Imaging Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Clinical Trial Imaging Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Anagram 4 Clinical Trials
- 14.1.2. Biospective Inc.
- 14.1.3. BioTelemetry by Koninklijke Philips N.V.
- 14.1.4. Boston Imaging Core Lab LLC
- 14.1.5. Calyx Group
- 14.1.6. Cardiovascular Imaging Technologies LLC
- 14.1.7. Clario
- 14.1.8. Dassault Systèmes
- 14.1.9. Icon PLC
- 14.1.10. Imaging Endpoints LI, LLC
- 14.1.11. Ixico PLC
- 14.1.12. Medical Metrics Inc. by Catalent, Inc.
- 14.1.13. Micron Inc.
- 14.1.14. ProScan Imaging LLC
- 14.1.15. Resonance Health Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. CLINICAL TRIAL IMAGING MARKET RESEARCH PROCESS
- FIGURE 2. CLINICAL TRIAL IMAGING MARKET SIZE, 2023 VS 2030
- FIGURE 3. CLINICAL TRIAL IMAGING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. CLINICAL TRIAL IMAGING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. CLINICAL TRIAL IMAGING MARKET DYNAMICS
- FIGURE 7. CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
- FIGURE 8. CLINICAL TRIAL IMAGING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
- FIGURE 10. CLINICAL TRIAL IMAGING MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
- FIGURE 12. CLINICAL TRIAL IMAGING MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. CLINICAL TRIAL IMAGING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES CLINICAL TRIAL IMAGING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL IMAGING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. CLINICAL TRIAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. CLINICAL TRIAL IMAGING MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.